Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiotherapy with 776C85, 5-FU and Hydroxyurea in Poor Prognosis Oral Cancer
NCT00004901Phase 2Completed
- Sponsor
- Robert H. Lurie Comprehensive Cancer Center
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eniluracil in oral cancer, laryngeal cancer, sponsored by Robert H. Lurie Comprehensive Cancer Center. Started Oct 1999; status: completed.
02
Drugs
eniluracil
03
Conditions
oral cancerlaryngeal cancer
Beyond the preview
Go deeper on NCT00004901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004901.